

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.86126182 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.86126182 |
| 3 | negative T cell selection (GO:0043383) | 5.20203535 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.08423445 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.57857863 |
| 6 | thymic T cell selection (GO:0045061) | 4.23429606 |
| 7 | response to interleukin-15 (GO:0070672) | 4.19119953 |
| 8 | T cell selection (GO:0045058) | 4.16976186 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.15638689 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.15638689 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.14126731 |
| 12 | positive T cell selection (GO:0043368) | 4.02983503 |
| 13 | regulation of regulatory T cell differentiation (GO:0045589) | 4.01889305 |
| 14 | positive regulation of granulocyte differentiation (GO:0030854) | 3.95661846 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.93808118 |
| 16 | regulation of T cell tolerance induction (GO:0002664) | 3.89654674 |
| 17 | detection of bacterium (GO:0016045) | 3.89034497 |
| 18 | detection of other organism (GO:0098543) | 3.80861516 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.79140742 |
| 20 | tolerance induction (GO:0002507) | 3.77369790 |
| 21 | T cell migration (GO:0072678) | 3.76847822 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73541169 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 3.72633192 |
| 24 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.64970682 |
| 25 | signal complex assembly (GO:0007172) | 3.64922501 |
| 26 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.62292489 |
| 27 | neutrophil activation (GO:0042119) | 3.58806343 |
| 28 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.53403182 |
| 29 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.53403182 |
| 30 | regulation of tolerance induction (GO:0002643) | 3.52690161 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.47996888 |
| 32 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.44233567 |
| 33 | fatty acid elongation (GO:0030497) | 3.42216588 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.41543712 |
| 35 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.40557409 |
| 36 | activated T cell proliferation (GO:0050798) | 3.39864819 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.32749325 |
| 38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31098603 |
| 39 | dendritic cell chemotaxis (GO:0002407) | 3.30697993 |
| 40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.25061145 |
| 41 | cellular extravasation (GO:0045123) | 3.22968324 |
| 42 | positive regulation of tolerance induction (GO:0002645) | 3.22886524 |
| 43 | amyloid precursor protein catabolic process (GO:0042987) | 3.21375278 |
| 44 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19329843 |
| 45 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.18259572 |
| 46 | granulocyte activation (GO:0036230) | 3.18139688 |
| 47 | leukocyte degranulation (GO:0043299) | 3.14628963 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08694633 |
| 49 | regulation of defense response to virus by virus (GO:0050690) | 3.08320147 |
| 50 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.04710364 |
| 51 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.04708014 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.04708014 |
| 53 | T cell receptor signaling pathway (GO:0050852) | 3.03968123 |
| 54 | regulation of platelet aggregation (GO:0090330) | 3.03031167 |
| 55 | dendritic cell migration (GO:0036336) | 3.01246872 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.99589572 |
| 57 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98986947 |
| 58 | pinocytosis (GO:0006907) | 2.97573535 |
| 59 | leukocyte aggregation (GO:0070486) | 2.96953456 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 2.96303279 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 2.96003845 |
| 62 | negative regulation of phagocytosis (GO:0050765) | 2.95684208 |
| 63 | positive regulation of isotype switching (GO:0045830) | 2.93497339 |
| 64 | macrophage activation involved in immune response (GO:0002281) | 2.90610161 |
| 65 | positive regulation of interleukin-4 production (GO:0032753) | 2.90225643 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90178995 |
| 67 | detection of external biotic stimulus (GO:0098581) | 2.87588389 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87335038 |
| 69 | mast cell activation (GO:0045576) | 2.87113134 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.86834787 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 2.86040900 |
| 72 | negative regulation of type 2 immune response (GO:0002829) | 2.86013414 |
| 73 | type I interferon signaling pathway (GO:0060337) | 2.85470334 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.85470334 |
| 75 | response to type I interferon (GO:0034340) | 2.85012114 |
| 76 | central nervous system myelination (GO:0022010) | 2.84864841 |
| 77 | axon ensheathment in central nervous system (GO:0032291) | 2.84864841 |
| 78 | negative regulation of stress fiber assembly (GO:0051497) | 2.84675989 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.84509075 |
| 80 | regulation of granulocyte differentiation (GO:0030852) | 2.81823021 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 2.81815301 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.80869674 |
| 83 | L-phenylalanine catabolic process (GO:0006559) | 2.77581882 |
| 84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77581882 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75774920 |
| 86 | ribosomal small subunit assembly (GO:0000028) | 2.75734732 |
| 87 | negative regulation of innate immune response (GO:0045824) | 2.75051955 |
| 88 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.74111838 |
| 89 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73392191 |
| 90 | T cell homeostasis (GO:0043029) | 2.73279633 |
| 91 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.72906817 |
| 92 | lymphocyte homeostasis (GO:0002260) | 2.72162706 |
| 93 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.71615184 |
| 94 | regulation of T cell mediated immunity (GO:0002709) | 2.71387566 |
| 95 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.68567208 |
| 96 | viral transcription (GO:0019083) | 2.67936443 |
| 97 | heme transport (GO:0015886) | 2.66829659 |
| 98 | response to laminar fluid shear stress (GO:0034616) | 2.66692076 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 2.65888382 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64120063 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64025802 |
| 102 | * amyloid precursor protein metabolic process (GO:0042982) | 2.63326441 |
| 103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.63198952 |
| 104 | L-phenylalanine metabolic process (GO:0006558) | 2.63198952 |
| 105 | pentose-phosphate shunt (GO:0006098) | 2.61933344 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.53728023 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.53728023 |
| 108 | translational termination (GO:0006415) | 2.50543487 |
| 109 | regulation of lipoprotein metabolic process (GO:0050746) | 2.50063762 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47686012 |
| 111 | response to lipoprotein particle (GO:0055094) | 2.46515216 |
| 112 | definitive hemopoiesis (GO:0060216) | 2.46514047 |
| 113 | NADPH regeneration (GO:0006740) | 2.45879401 |
| 114 | protein carboxylation (GO:0018214) | 2.45636613 |
| 115 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.45636613 |
| 116 | plasma lipoprotein particle clearance (GO:0034381) | 2.44831775 |
| 117 | pentose metabolic process (GO:0019321) | 2.43346516 |
| 118 | response to muramyl dipeptide (GO:0032495) | 2.43119677 |
| 119 | adhesion of symbiont to host (GO:0044406) | 2.43059021 |
| 120 | respiratory burst (GO:0045730) | 2.41735654 |
| 121 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39915813 |
| 122 | creatine metabolic process (GO:0006600) | 2.36468135 |
| 123 | angiogenesis involved in wound healing (GO:0060055) | 2.35373414 |
| 124 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.35303131 |
| 125 | ribosomal small subunit biogenesis (GO:0042274) | 2.29078740 |
| 126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.27961299 |
| 127 | hemidesmosome assembly (GO:0031581) | 2.26552083 |
| 128 | very long-chain fatty acid metabolic process (GO:0000038) | 2.26470327 |
| 129 | sulfur amino acid catabolic process (GO:0000098) | 2.25965417 |
| 130 | regulation of superoxide anion generation (GO:0032928) | 2.24961465 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.24637701 |
| 132 | low-density lipoprotein particle clearance (GO:0034383) | 2.24011477 |
| 133 | regulation of cholesterol storage (GO:0010885) | 2.23891009 |
| 134 | membrane raft organization (GO:0031579) | 2.23348361 |
| 135 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.22415373 |
| 136 | negative regulation of viral entry into host cell (GO:0046597) | 2.19837655 |
| 137 | regulation of triglyceride catabolic process (GO:0010896) | 2.18451361 |
| 138 | fibrinolysis (GO:0042730) | 2.18420617 |
| 139 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.18322010 |
| 140 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.18322010 |
| 141 | defense response to fungus (GO:0050832) | 2.17966520 |
| 142 | primary alcohol catabolic process (GO:0034310) | 2.17708936 |
| 143 | aromatic amino acid family catabolic process (GO:0009074) | 2.17290129 |
| 144 | protein targeting to ER (GO:0045047) | 2.17128649 |
| 145 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.17011446 |
| 146 | negative regulation of chemokine production (GO:0032682) | 2.15573251 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.14937092 |
| 148 | membrane protein ectodomain proteolysis (GO:0006509) | 2.14507257 |
| 149 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.14047442 |
| 150 | modulation by symbiont of host immune response (GO:0052553) | 2.14047442 |
| 151 | positive regulation by symbiont of host defense response (GO:0052509) | 2.14047442 |
| 152 | modulation by symbiont of host defense response (GO:0052031) | 2.14047442 |
| 153 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.14047442 |
| 154 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.14047442 |
| 155 | ethanol metabolic process (GO:0006067) | 2.13811019 |
| 156 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.13561093 |
| 157 | immunoglobulin mediated immune response (GO:0016064) | 2.13407198 |
| 158 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.13327014 |
| 159 | alpha-linolenic acid metabolic process (GO:0036109) | 2.13129315 |
| 160 | cotranslational protein targeting to membrane (GO:0006613) | 2.12871491 |
| 161 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.12626795 |
| 162 | cysteine metabolic process (GO:0006534) | 2.11546577 |
| 163 | bile acid and bile salt transport (GO:0015721) | 2.11058826 |
| 164 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.10633197 |
| 165 | megakaryocyte development (GO:0035855) | 2.09594016 |
| 166 | negative regulation of lipid storage (GO:0010888) | 2.07470907 |
| 167 | protein localization to endoplasmic reticulum (GO:0070972) | 2.06716549 |
| 168 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.06479020 |
| 169 | glyoxylate metabolic process (GO:0046487) | 2.06311837 |
| 170 | regulation of antigen processing and presentation (GO:0002577) | 2.05943137 |
| 171 | response to peptidoglycan (GO:0032494) | 2.05852601 |
| 172 | negative regulation of fibrinolysis (GO:0051918) | 2.05842759 |
| 173 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.05646357 |
| 174 | adhesion of symbiont to host cell (GO:0044650) | 2.05398604 |
| 175 | virion attachment to host cell (GO:0019062) | 2.05398604 |
| 176 | regulation of B cell differentiation (GO:0045577) | 2.04791806 |
| 177 | negative regulation of acute inflammatory response (GO:0002674) | 2.04609839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75692971 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.71297118 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.07276211 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86804424 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67321718 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54735277 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51432971 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.48284874 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46049151 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.44413930 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41705821 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.33132807 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31886046 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26602075 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16944931 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12816024 |
| 17 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.08030113 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04077171 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00269061 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97182086 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95618513 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.94805480 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92317067 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89669261 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88500095 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86139962 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85719905 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85113389 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81447250 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80142735 |
| 31 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.77427192 |
| 32 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.75191350 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.73437814 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.66817986 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66408343 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65251871 |
| 37 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64620762 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63887898 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.62850675 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60658031 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.57057269 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56060496 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52595336 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50083221 |
| 45 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48591481 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46843912 |
| 47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.46499141 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42520079 |
| 49 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40330487 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38254417 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37991721 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37523631 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.36300069 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.36075368 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.35838149 |
| 56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34666840 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34060950 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32984737 |
| 59 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32309132 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31095153 |
| 61 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27915164 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27767777 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27361144 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27221414 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26835645 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25792218 |
| 67 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25329237 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25241646 |
| 69 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24593659 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23849655 |
| 71 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23627490 |
| 72 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22547675 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22547300 |
| 74 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22451627 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21962435 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21818161 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21542290 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18246114 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18232184 |
| 80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18142630 |
| 81 | * MAF_26560356_Chip-Seq_TH2_Human | 1.17452537 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17345356 |
| 83 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16514533 |
| 84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16443254 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15004020 |
| 86 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13715133 |
| 87 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12850686 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.12601211 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12354422 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12023586 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11178634 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10838431 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10815467 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10050835 |
| 95 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09725486 |
| 96 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09458126 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08770311 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08693182 |
| 99 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.08166935 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07746332 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07616496 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06759080 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06398239 |
| 104 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06345422 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05302980 |
| 106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04623595 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03704394 |
| 108 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03637473 |
| 109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03049453 |
| 110 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02683406 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02433451 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02056474 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01871972 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99215710 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99100078 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98936102 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98710093 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97598168 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97163566 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96953775 |
| 121 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96780346 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95430556 |
| 123 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95104093 |
| 124 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93556434 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93095703 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92911133 |
| 127 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.92631257 |
| 128 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92108801 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90524690 |
| 130 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90185094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 2.63497620 |
| 2 | MP0005058_abnormal_lysosome_morphology | 2.44524436 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 2.35654035 |
| 4 | MP0003724_increased_susceptibility_to | 2.09049761 |
| 5 | MP0003436_decreased_susceptibility_to | 2.09035007 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 2.07323820 |
| 7 | MP0000703_abnormal_thymus_morphology | 2.02569054 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 1.96855593 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 1.95498739 |
| 10 | MP0005360_urolithiasis | 1.95218364 |
| 11 | MP0000685_abnormal_immune_system | 1.94527750 |
| 12 | MP0009785_altered_susceptibility_to | 1.88062531 |
| 13 | MP0005464_abnormal_platelet_physiology | 1.87459988 |
| 14 | MP0001835_abnormal_antigen_presentation | 1.86568450 |
| 15 | MP0002419_abnormal_innate_immunity | 1.82790052 |
| 16 | MP0005025_abnormal_response_to | 1.77844513 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 1.73685445 |
| 18 | MP0004381_abnormal_hair_follicle | 1.72770328 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.70130402 |
| 20 | MP0005365_abnormal_bile_salt | 1.69651334 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.67708140 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66953700 |
| 23 | MP0004947_skin_inflammation | 1.66490327 |
| 24 | MP0006082_CNS_inflammation | 1.65779607 |
| 25 | MP0008260_abnormal_autophagy | 1.61498248 |
| 26 | MP0000383_abnormal_hair_follicle | 1.60415957 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.60106399 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.60003966 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.56048528 |
| 30 | MP0001800_abnormal_humoral_immune | 1.52971975 |
| 31 | MP0004510_myositis | 1.52801846 |
| 32 | MP0008004_abnormal_stomach_pH | 1.52196026 |
| 33 | MP0005387_immune_system_phenotype | 1.51825582 |
| 34 | MP0001790_abnormal_immune_system | 1.51825582 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.50405089 |
| 36 | MP0003303_peritoneal_inflammation | 1.50016834 |
| 37 | MP0002723_abnormal_immune_serum | 1.47337507 |
| 38 | MP0005671_abnormal_response_to | 1.46285200 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.44168088 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.43720270 |
| 41 | MP0001819_abnormal_immune_cell | 1.42629331 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.42201603 |
| 43 | MP0000920_abnormal_myelination | 1.41832337 |
| 44 | MP0005451_abnormal_body_composition | 1.40892967 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.40790274 |
| 46 | MP0003828_pulmonary_edema | 1.40214404 |
| 47 | MP0001851_eye_inflammation | 1.39054116 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.37904604 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.37577780 |
| 50 | MP0002796_impaired_skin_barrier | 1.35547200 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.34409993 |
| 52 | MP0001873_stomach_inflammation | 1.34003129 |
| 53 | MP0009278_abnormal_bone_marrow | 1.31614178 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.30420670 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.30420670 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.29131559 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.27903261 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.27846955 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.27788724 |
| 60 | MP0004130_abnormal_muscle_cell | 1.26993978 |
| 61 | MP0005023_abnormal_wound_healing | 1.25418794 |
| 62 | MP0002060_abnormal_skin_morphology | 1.25316594 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.24729560 |
| 64 | MP0005083_abnormal_biliary_tract | 1.23900051 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.20886950 |
| 66 | MP0008469_abnormal_protein_level | 1.20759420 |
| 67 | MP0002398_abnormal_bone_marrow | 1.20188536 |
| 68 | MP0000716_abnormal_immune_system | 1.19851518 |
| 69 | MP0002933_joint_inflammation | 1.19251125 |
| 70 | MP0005310_abnormal_salivary_gland | 1.18909610 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.18854850 |
| 72 | MP0001666_abnormal_nutrient_absorption | 1.18846989 |
| 73 | MP0002722_abnormal_immune_system | 1.14820444 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 1.14581317 |
| 75 | MP0002405_respiratory_system_inflammati | 1.14179303 |
| 76 | MP0003186_abnormal_redox_activity | 1.13069380 |
| 77 | MP0000609_abnormal_liver_physiology | 1.13054011 |
| 78 | MP0006054_spinal_hemorrhage | 1.12502733 |
| 79 | MP0001216_abnormal_epidermal_layer | 1.12464455 |
| 80 | MP0002429_abnormal_blood_cell | 1.10251391 |
| 81 | MP0001853_heart_inflammation | 1.09349947 |
| 82 | MP0004883_abnormal_blood_vessel | 1.09280787 |
| 83 | MP0002132_abnormal_respiratory_system | 1.08740545 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.05334947 |
| 85 | MP0002098_abnormal_vibrissa_morphology | 1.05029012 |
| 86 | MP0000377_abnormal_hair_follicle | 1.02617779 |
| 87 | * MP0010329_abnormal_lipoprotein_level | 1.02420380 |
| 88 | MP0009763_increased_sensitivity_to | 1.01021819 |
| 89 | MP0005501_abnormal_skin_physiology | 1.00819445 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.98969398 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 0.98359300 |
| 92 | MP0003195_calcinosis | 0.95867806 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.93726896 |
| 94 | MP0003045_fibrosis | 0.92417759 |
| 95 | MP0001663_abnormal_digestive_system | 0.91804226 |
| 96 | MP0000490_abnormal_crypts_of | 0.90434791 |
| 97 | MP0001243_abnormal_dermal_layer | 0.89755923 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.89614309 |
| 99 | MP0008874_decreased_physiological_sensi | 0.88912999 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.88791060 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.88499607 |
| 102 | * MP0002118_abnormal_lipid_homeostasis | 0.88181002 |
| 103 | MP0009931_abnormal_skin_appearance | 0.87104760 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.85384953 |
| 105 | MP0000858_altered_metastatic_potential | 0.85246710 |
| 106 | MP0009764_decreased_sensitivity_to | 0.84967013 |
| 107 | MP0004147_increased_porphyrin_level | 0.84485116 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.84430720 |
| 109 | MP0003866_abnormal_defecation | 0.84221891 |
| 110 | MP0003448_altered_tumor_morphology | 0.84012308 |
| 111 | MP0000598_abnormal_liver_morphology | 0.82954180 |
| 112 | MP0003075_altered_response_to | 0.82723727 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.82103999 |
| 114 | MP0003690_abnormal_glial_cell | 0.81978981 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.81408938 |
| 116 | MP0003252_abnormal_bile_duct | 0.79967803 |
| 117 | MP0005166_decreased_susceptibility_to | 0.79302716 |
| 118 | MP0000249_abnormal_blood_vessel | 0.78705497 |
| 119 | MP0000343_altered_response_to | 0.77474341 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.75045966 |
| 121 | MP0003795_abnormal_bone_structure | 0.74673885 |
| 122 | MP0005164_abnormal_response_to | 0.74400033 |
| 123 | MP0005390_skeleton_phenotype | 0.73842345 |
| 124 | MP0000604_amyloidosis | 0.73359162 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.71599775 |
| 126 | MP0003091_abnormal_cell_migration | 0.67717387 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.66755950 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.65989090 |
| 129 | MP0003879_abnormal_hair_cell | 0.63590926 |
| 130 | MP0008961_abnormal_basal_metabolism | 0.60340696 |
| 131 | * MP0009642_abnormal_blood_homeostasis | 0.60114282 |
| 132 | MP0002009_preneoplasia | 0.59421650 |
| 133 | MP0005409_darkened_coat_color | 0.59126697 |
| 134 | MP0001849_ear_inflammation | 0.58847268 |
| 135 | MP0003329_amyloid_beta_deposits | 0.58758046 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.57889064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 3.89565551 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 3.75282501 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.71843204 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 3.57421160 |
| 5 | Abnormality of T cell number (HP:0011839) | 3.52791474 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.52741743 |
| 7 | Chronic otitis media (HP:0000389) | 3.51734072 |
| 8 | Orchitis (HP:0100796) | 3.47875204 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.42636221 |
| 10 | Encephalitis (HP:0002383) | 3.27779778 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 3.25489002 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.23221906 |
| 13 | Inflammation of the large intestine (HP:0002037) | 3.22233140 |
| 14 | Gastrointestinal inflammation (HP:0004386) | 3.20760935 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.20721422 |
| 16 | Optic neuritis (HP:0100653) | 3.20721422 |
| 17 | Axonal loss (HP:0003447) | 3.17294600 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.16773898 |
| 19 | Abnormality of T cells (HP:0002843) | 3.14807536 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.13268621 |
| 21 | Meningitis (HP:0001287) | 3.09871813 |
| 22 | Pustule (HP:0200039) | 3.06993874 |
| 23 | Deep venous thrombosis (HP:0002625) | 2.95484751 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.86142880 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83350930 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83350930 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.78475300 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.75103455 |
| 29 | Epistaxis (HP:0000421) | 2.74634272 |
| 30 | Petechiae (HP:0000967) | 2.74488874 |
| 31 | Gingival bleeding (HP:0000225) | 2.73856084 |
| 32 | Increased IgM level (HP:0003496) | 2.73056848 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72791460 |
| 34 | Joint hemorrhage (HP:0005261) | 2.72103821 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71931141 |
| 36 | Episodic fever (HP:0001954) | 2.69354822 |
| 37 | Chest pain (HP:0100749) | 2.68871528 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.68415092 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.66188334 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.64204539 |
| 41 | Recurrent skin infections (HP:0001581) | 2.63693156 |
| 42 | Increased serum ferritin (HP:0003281) | 2.59271338 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58730602 |
| 44 | Gingivitis (HP:0000230) | 2.57461527 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.55203763 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.53046634 |
| 47 | Stomatitis (HP:0010280) | 2.50457261 |
| 48 | Colitis (HP:0002583) | 2.48581988 |
| 49 | * Xanthomatosis (HP:0000991) | 2.47675804 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.47322460 |
| 51 | Abnormality of iron homeostasis (HP:0011031) | 2.46963741 |
| 52 | Hypochromic anemia (HP:0001931) | 2.46308088 |
| 53 | Lymphopenia (HP:0001888) | 2.45253597 |
| 54 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42079017 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.39446032 |
| 56 | Purpura (HP:0000979) | 2.38233490 |
| 57 | Thoracic kyphosis (HP:0002942) | 2.37473706 |
| 58 | Abnormal platelet function (HP:0011869) | 2.36814350 |
| 59 | Impaired platelet aggregation (HP:0003540) | 2.36814350 |
| 60 | Thick nail (HP:0001805) | 2.36377477 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.36238388 |
| 62 | Loss of speech (HP:0002371) | 2.36115345 |
| 63 | Papilledema (HP:0001085) | 2.35196001 |
| 64 | Premature skin wrinkling (HP:0100678) | 2.32951044 |
| 65 | Slow saccadic eye movements (HP:0000514) | 2.31080263 |
| 66 | Parakeratosis (HP:0001036) | 2.30073020 |
| 67 | Myocardial infarction (HP:0001658) | 2.30043991 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.29224701 |
| 69 | Thrombocytosis (HP:0001894) | 2.28550508 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.26585005 |
| 71 | Menorrhagia (HP:0000132) | 2.26327339 |
| 72 | Severe combined immunodeficiency (HP:0004430) | 2.25546802 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.24774053 |
| 74 | Papilloma (HP:0012740) | 2.24406171 |
| 75 | Verrucae (HP:0200043) | 2.24406171 |
| 76 | * Hyperlipoproteinemia (HP:0010980) | 2.21700666 |
| 77 | Cellulitis (HP:0100658) | 2.20009772 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.19164517 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.17675967 |
| 80 | Anorexia (HP:0002039) | 2.14972907 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.14862570 |
| 82 | Microcytic anemia (HP:0001935) | 2.14402267 |
| 83 | Esophageal varix (HP:0002040) | 2.12716177 |
| 84 | Arterial thrombosis (HP:0004420) | 2.11943293 |
| 85 | Abnormality of the nasal mucosa (HP:0000433) | 2.11581250 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10846016 |
| 87 | Complement deficiency (HP:0004431) | 2.10626635 |
| 88 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10046098 |
| 89 | Osteolytic defects of the hand bones (HP:0009699) | 2.10046098 |
| 90 | Joint swelling (HP:0001386) | 2.09870255 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.09823292 |
| 92 | Amyloidosis (HP:0011034) | 2.08083800 |
| 93 | IgM deficiency (HP:0002850) | 2.07219646 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.07219178 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.06514292 |
| 96 | Myositis (HP:0100614) | 2.06252209 |
| 97 | Hemoptysis (HP:0002105) | 2.06175933 |
| 98 | IgG deficiency (HP:0004315) | 2.05958824 |
| 99 | Bruising susceptibility (HP:0000978) | 2.04812798 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.03366868 |
| 101 | Recurrent viral infections (HP:0004429) | 2.02501908 |
| 102 | Hypertensive crisis (HP:0100735) | 2.01839154 |
| 103 | Abnormal platelet volume (HP:0011876) | 2.01801629 |
| 104 | Periodontitis (HP:0000704) | 1.99706683 |
| 105 | Recurrent fungal infections (HP:0002841) | 1.99562793 |
| 106 | Obstructive lung disease (HP:0006536) | 1.98436752 |
| 107 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98436752 |
| 108 | Glomerulonephritis (HP:0000099) | 1.98295001 |
| 109 | Acute hepatic failure (HP:0006554) | 1.97895885 |
| 110 | Urticaria (HP:0001025) | 1.97522896 |
| 111 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97458963 |
| 112 | Autoimmune thrombocytopenia (HP:0001973) | 1.96485223 |
| 113 | Seborrheic dermatitis (HP:0001051) | 1.95963325 |
| 114 | Leukocytosis (HP:0001974) | 1.95284778 |
| 115 | Increased IgE level (HP:0003212) | 1.93185625 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92910832 |
| 117 | Skin ulcer (HP:0200042) | 1.92108025 |
| 118 | Dysostosis multiplex (HP:0000943) | 1.91631230 |
| 119 | Acne (HP:0001061) | 1.90847184 |
| 120 | Abnormality of complement system (HP:0005339) | 1.89256235 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.88769088 |
| 122 | Steatorrhea (HP:0002570) | 1.87878576 |
| 123 | Pulmonary embolism (HP:0002204) | 1.87654471 |
| 124 | Osteomyelitis (HP:0002754) | 1.87447863 |
| 125 | Ectropion (HP:0000656) | 1.87158952 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.87001592 |
| 127 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85841811 |
| 128 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.85682938 |
| 129 | Nasal polyposis (HP:0100582) | 1.84731966 |
| 130 | Premature rupture of membranes (HP:0001788) | 1.83582701 |
| 131 | Eosinophilia (HP:0001880) | 1.82352716 |
| 132 | Polycythemia (HP:0001901) | 1.82242538 |
| 133 | Fat malabsorption (HP:0002630) | 1.82188562 |
| 134 | Chronic diarrhea (HP:0002028) | 1.81910097 |
| 135 | Abnormality of eosinophils (HP:0001879) | 1.81633446 |
| 136 | Nonimmune hydrops fetalis (HP:0001790) | 1.80008067 |
| 137 | Alopecia of scalp (HP:0002293) | 1.78421499 |
| 138 | Abnormality of T cell physiology (HP:0011840) | 1.78373011 |
| 139 | Sepsis (HP:0100806) | 1.78131684 |
| 140 | Obstructive sleep apnea (HP:0002870) | 1.77145421 |
| 141 | Vasculitis (HP:0002633) | 1.76944682 |
| 142 | Recurrent bronchitis (HP:0002837) | 1.75958249 |
| 143 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75536099 |
| 144 | Erythroderma (HP:0001019) | 1.74319158 |
| 145 | Nephritis (HP:0000123) | 1.73301936 |
| 146 | Granulocytopenia (HP:0001913) | 1.72626341 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.72115903 |
| 148 | Abnormality of methionine metabolism (HP:0010901) | 1.71760869 |
| 149 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71722483 |
| 150 | Peripheral demyelination (HP:0011096) | 1.71532972 |
| 151 | Macrocytic anemia (HP:0001972) | 1.71437884 |
| 152 | Hypotrichosis (HP:0001006) | 1.71308105 |
| 153 | Ulnar bowing (HP:0003031) | 1.69928779 |
| 154 | Stridor (HP:0010307) | 1.69562040 |
| 155 | Pruritus (HP:0000989) | 1.65800359 |
| 156 | Ileus (HP:0002595) | 1.65389533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.27573496 |
| 2 | EPHB1 | 3.57979207 |
| 3 | PRPF4B | 2.96242016 |
| 4 | MAP4K1 | 2.94741363 |
| 5 | MST1R | 2.67668585 |
| 6 | TAOK3 | 2.46139989 |
| 7 | FES | 2.28968161 |
| 8 | TNK2 | 2.27914577 |
| 9 | NME2 | 2.21510508 |
| 10 | ERN1 | 2.18317587 |
| 11 | KIT | 2.10298350 |
| 12 | BLK | 2.02679967 |
| 13 | MAP2K3 | 1.97484474 |
| 14 | STK10 | 1.96675355 |
| 15 | KDR | 1.92904356 |
| 16 | TGFBR2 | 1.86844828 |
| 17 | MET | 1.82707462 |
| 18 | MAP3K13 | 1.81728942 |
| 19 | TBK1 | 1.77176306 |
| 20 | FGFR4 | 1.75981650 |
| 21 | TYK2 | 1.73444260 |
| 22 | EEF2K | 1.63433127 |
| 23 | BTK | 1.59249812 |
| 24 | MAPKAPK5 | 1.54878035 |
| 25 | MAP2K2 | 1.52528088 |
| 26 | IKBKE | 1.49840685 |
| 27 | TAOK1 | 1.48609775 |
| 28 | BCKDK | 1.48509780 |
| 29 | IRAK4 | 1.43390231 |
| 30 | CLK1 | 1.42395103 |
| 31 | MAP3K3 | 1.41940509 |
| 32 | TIE1 | 1.40942022 |
| 33 | JAK3 | 1.40518758 |
| 34 | ITK | 1.40250153 |
| 35 | PIM2 | 1.38547437 |
| 36 | LRRK2 | 1.34504576 |
| 37 | TEC | 1.33796399 |
| 38 | SIK3 | 1.30757184 |
| 39 | CSF1R | 1.28423520 |
| 40 | STK39 | 1.28171514 |
| 41 | RPS6KB2 | 1.27211830 |
| 42 | BMX | 1.26666459 |
| 43 | ZAP70 | 1.25382982 |
| 44 | SMG1 | 1.19711699 |
| 45 | IKBKB | 1.18180908 |
| 46 | NLK | 1.17869275 |
| 47 | TRPM7 | 1.17549139 |
| 48 | TAOK2 | 1.17451802 |
| 49 | EPHA2 | 1.12302017 |
| 50 | PIK3CA | 1.07667263 |
| 51 | FLT3 | 1.06645441 |
| 52 | MARK3 | 1.06348387 |
| 53 | KSR2 | 1.04796935 |
| 54 | TGFBR1 | 1.03670027 |
| 55 | CAMKK1 | 1.03386812 |
| 56 | PKN2 | 1.03258293 |
| 57 | MAP3K7 | 1.03076467 |
| 58 | SIK1 | 1.02641957 |
| 59 | PASK | 1.02491828 |
| 60 | PDK1 | 1.02449403 |
| 61 | STK4 | 1.02436283 |
| 62 | MARK2 | 1.01846991 |
| 63 | FGR | 1.01812200 |
| 64 | TRIB3 | 1.01338665 |
| 65 | TESK2 | 0.99643790 |
| 66 | CAMKK2 | 0.98440046 |
| 67 | TTN | 0.98328605 |
| 68 | MAP3K14 | 0.97008595 |
| 69 | CSK | 0.95684165 |
| 70 | TXK | 0.95225107 |
| 71 | PRKD2 | 0.93768914 |
| 72 | LCK | 0.93607853 |
| 73 | PIM1 | 0.93113043 |
| 74 | PTK2B | 0.90176697 |
| 75 | PDPK1 | 0.88750629 |
| 76 | FGFR3 | 0.88196216 |
| 77 | CDK12 | 0.86649451 |
| 78 | RPS6KA4 | 0.85211585 |
| 79 | HIPK2 | 0.84770007 |
| 80 | CDC42BPA | 0.84768704 |
| 81 | IRAK3 | 0.84708009 |
| 82 | MAP3K8 | 0.83692745 |
| 83 | PAK4 | 0.83360792 |
| 84 | PTK6 | 0.80881000 |
| 85 | HCK | 0.79789744 |
| 86 | YES1 | 0.78812208 |
| 87 | STK38 | 0.77754591 |
| 88 | PBK | 0.76608997 |
| 89 | GRK6 | 0.74684414 |
| 90 | MAP3K11 | 0.73410149 |
| 91 | JAK2 | 0.70226009 |
| 92 | EPHA3 | 0.70154088 |
| 93 | SYK | 0.68867093 |
| 94 | RPS6KA5 | 0.68718386 |
| 95 | MST4 | 0.68696108 |
| 96 | WEE1 | 0.68418701 |
| 97 | OXSR1 | 0.66997912 |
| 98 | LYN | 0.66322976 |
| 99 | CDK4 | 0.65544514 |
| 100 | FGFR2 | 0.64969082 |
| 101 | MAP2K6 | 0.62931040 |
| 102 | MAPK15 | 0.62084250 |
| 103 | MAP3K10 | 0.60890012 |
| 104 | CDK6 | 0.60617312 |
| 105 | SIK2 | 0.58990340 |
| 106 | FYN | 0.58331693 |
| 107 | CDK19 | 0.57687143 |
| 108 | MAP3K2 | 0.57202044 |
| 109 | PIK3CG | 0.56882787 |
| 110 | BMPR2 | 0.56762190 |
| 111 | MAPK4 | 0.56365897 |
| 112 | MAPKAPK3 | 0.56342517 |
| 113 | MAPK7 | 0.54894760 |
| 114 | BUB1 | 0.54375551 |
| 115 | JAK1 | 0.53723797 |
| 116 | MAPK11 | 0.53206785 |
| 117 | IRAK2 | 0.50920196 |
| 118 | MAPKAPK2 | 0.50544276 |
| 119 | MAP3K1 | 0.50348208 |
| 120 | PRKG2 | 0.50023243 |
| 121 | RET | 0.49543727 |
| 122 | SGK3 | 0.48846310 |
| 123 | CSNK1A1L | 0.46758699 |
| 124 | CSNK1G3 | 0.46422745 |
| 125 | PAK2 | 0.46058814 |
| 126 | MAPK12 | 0.44341162 |
| 127 | CSNK1G1 | 0.43963690 |
| 128 | GRK5 | 0.43549841 |
| 129 | PKN1 | 0.43297602 |
| 130 | RIPK1 | 0.43296927 |
| 131 | DYRK3 | 0.42736446 |
| 132 | ABL1 | 0.42620629 |
| 133 | NEK9 | 0.41073137 |
| 134 | PRKCQ | 0.40478857 |
| 135 | PRKD1 | 0.40260288 |
| 136 | ARAF | 0.39531424 |
| 137 | CDK7 | 0.38605496 |
| 138 | PLK4 | 0.36807649 |
| 139 | RPS6KA6 | 0.36190703 |
| 140 | ILK | 0.35253348 |
| 141 | MELK | 0.34974604 |
| 142 | RAF1 | 0.33223850 |
| 143 | DYRK1B | 0.33121466 |
| 144 | IRAK1 | 0.31400553 |
| 145 | PDGFRB | 0.31387723 |
| 146 | ICK | 0.30638884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.47655124 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.37133167 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28428213 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.23690740 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04031221 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.03766362 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96480307 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91503243 |
| 9 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.82988523 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82595671 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.80307662 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78536329 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72886195 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68037707 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64595103 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.64231621 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.61343050 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.57209244 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50058410 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43930872 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.43000509 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41492780 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40654589 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40350692 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39661974 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.37156663 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36084590 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35438421 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34972758 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29832088 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28803442 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28604107 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.26607089 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26445917 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.24241828 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23695889 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23582264 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22829577 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21685073 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.19710736 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17767482 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16557745 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15794421 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15687738 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15672151 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12995446 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.12892202 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12656227 |
| 49 | * Endocytosis_Homo sapiens_hsa04144 | 1.10996521 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09948734 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09341267 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08373413 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07366070 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06632514 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04969120 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.04408653 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03819795 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03717593 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02521647 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02235199 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99705166 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.98511559 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98388345 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97364578 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96978719 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96888198 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95137350 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.94487855 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94385756 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93736796 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92116509 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91966958 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91815340 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91136999 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90240828 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90134815 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89720317 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87068287 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86404138 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86136946 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.86102439 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85718099 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.84317053 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83291148 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82717672 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82274012 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.82028152 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80215955 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79922286 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78504712 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78316316 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77641733 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77348328 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77168184 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76566641 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76512477 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76382853 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.76012776 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75767835 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75717791 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75538934 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75103505 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74316588 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73686037 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.71119931 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70567007 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69782198 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.69538238 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68939009 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.68523159 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.68238892 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68110448 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67490162 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66698774 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66314345 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66074248 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65896068 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65510426 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.65308260 |
| 120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64797819 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64665528 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64524247 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64371011 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63906492 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63514508 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62240674 |
| 127 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62019170 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60502753 |
| 129 | Legionellosis_Homo sapiens_hsa05134 | 0.59506409 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59499051 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59208948 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59123613 |
| 133 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58624177 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57377500 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56366101 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54918369 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54635713 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54148186 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54063001 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52949048 |
| 141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52880380 |
| 142 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52159118 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51805290 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51676062 |
| 145 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49747391 |
| 146 | Prostate cancer_Homo sapiens_hsa05215 | 0.48728239 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.48555852 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48310494 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.47617158 |
| 150 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47263978 |
| 151 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47178061 |
| 152 | Glioma_Homo sapiens_hsa05214 | 0.46100664 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45432947 |
| 154 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43898866 |
| 155 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43777019 |
| 156 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42699627 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42506874 |
| 158 | Bile secretion_Homo sapiens_hsa04976 | 0.42317405 |
| 159 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42050972 |
| 160 | DNA replication_Homo sapiens_hsa03030 | 0.41920131 |
| 161 | Protein export_Homo sapiens_hsa03060 | 0.41377530 |

